Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clinical spectrum of STX1B-related epileptic disorders.

Wolking S, May P, Mei D, Møller RS, Balestrini S, Helbig KL, Altuzarra CD, Chatron N, Kaiwar C, Stöhr K, Widdess-Walsh P, Mendelsohn BA, Numis A, Cilio MR, Van Paesschen W, Svendsen LL, Oates S, Hughes E, Goyal S, Brown K, Sifuentes Saenz M, Dorn T, Muhle H, Pagnamenta AT, Vavoulis DV, Knight SJL, Taylor JC, Canevini MP, Darra F, Gavrilova RH, Powis Z, Tang S, Marquetand J, Armstrong M, McHale D, Klee EW, Kluger GJ, Lowenstein DH, Weckhuysen S, Pal DK, Helbig I, Guerrini R, Thomas RH, Rees MI, Lesca G, Sisodiya SM, Weber YG, Lal D, Marini C, Lerche H, Schubert J.

Neurology. 2019 Feb 8. pii: 10.1212/WNL.0000000000007089. doi: 10.1212/WNL.0000000000007089. [Epub ahead of print]

PMID:
30737342
2.

Lack of response to quinidine in KCNT1-related neonatal epilepsy.

Numis AL, Nair U, Datta AN, Sands TT, Oldham MS, Patel A, Li M, Gazina E, Petrou S, Cilio MR.

Epilepsia. 2018 Oct;59(10):1889-1898. doi: 10.1111/epi.14551. Epub 2018 Sep 4.

PMID:
30182418
3.

Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy.

Singhal NS, Numis AL, Lee MB, Chang EF, Sullivan JE, Auguste KI, Rao VR.

Epilepsy Behav Case Rep. 2018 Mar 12;10:21-24. doi: 10.1016/j.ebcr.2018.02.002. eCollection 2018.

4.

Outcomes After Acute Symptomatic Seizures in Children Admitted to a Neonatal Neurocritical Care Service.

Glass HC, Numis AL, Gano D, Bali V, Rogers EE.

Pediatr Neurol. 2018 Jul;84:39-45. doi: 10.1016/j.pediatrneurol.2018.03.016. Epub 2018 Apr 20.

PMID:
29886041
5.

Population-based study of ischemic stroke risk after trauma in children and young adults.

Fox CK, Hills NK, Vinson DR, Numis AL, Dicker RA, Sidney S, Fullerton HJ.

Neurology. 2017 Dec 5;89(23):2310-2316. doi: 10.1212/WNL.0000000000004708. Epub 2017 Nov 8.

6.

AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software.

Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, Numis AL, Ho MG, Rao L, Bhat A, Suski J, Asadollahi M, Ambrose T, Fernandez A, Nei M, Skidmore C, Mintzer S, Eliashiv DS, Mathern GW, Nuwer MR, Sperling M, Engel J Jr, Stern JM.

Version 2. F1000Res. 2017 Jan 10 [revised 2017 Jan 1];6:30. doi: 10.12688/f1000research.10569.2. eCollection 2017.

7.

WONOEP appraisal: Biomarkers of epilepsy-associated comorbidities.

Ravizza T, Onat FY, Brooks-Kayal AR, Depaulis A, Galanopoulou AS, Mazarati A, Numis AL, Sankar R, Friedman A.

Epilepsia. 2017 Mar;58(3):331-342. doi: 10.1111/epi.13652. Epub 2016 Dec 30. Review.

8.

Cerebral palsy research funding from the National Institutes of Health, 2001 to 2013.

Wu YW, Mehravari AS, Numis AL, Gross P.

Dev Med Child Neurol. 2015 Oct;57(10):936-41. doi: 10.1111/dmcn.12789. Epub 2015 May 6.

9.

Early and effective treatment of KCNQ2 encephalopathy.

Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, Podesta B, Thibert RL, Shapiro KA, Guerrini R, Scheffer IE, Marini C, Cilio MR.

Epilepsia. 2015 May;56(5):685-91. doi: 10.1111/epi.12984. Epub 2015 Apr 16.

10.

Arterial ischemic stroke in children: risk factors and etiologies.

Numis AL, Fox CK.

Curr Neurol Neurosci Rep. 2014 Jan;14(1):422. doi: 10.1007/s11910-013-0422-8. Review.

11.

KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response.

Numis AL, Angriman M, Sullivan JE, Lewis AJ, Striano P, Nabbout R, Cilio MR.

Neurology. 2014 Jan 28;82(4):368-70. doi: 10.1212/WNL.0000000000000060. Epub 2013 Dec 26.

12.

Intraoperative rerupture during surgical treatment of aneurysmal subarachnoid hemorrhage is not associated with an increased risk of vasospasm.

Sheth SA, Hausrath D, Numis AL, Lawton MT, Josephson SA.

J Neurosurg. 2014 Feb;120(2):409-14. doi: 10.3171/2013.10.JNS13934. Epub 2013 Dec 6.

PMID:
24313615
13.

Multifocal micronodular pneumocyte hyperplasia: computed tomographic appearance and follow-up in tuberous sclerosis complex.

Muzykewicz DA, Black ME, Muse V, Numis AL, Rajagopal J, Thiele EA, Sharma A.

J Comput Assist Tomogr. 2012 Sep-Oct;36(5):518-22.

PMID:
22992599
14.

The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms.

Numis AL, Yellen MB, Chu-Shore CJ, Pfeifer HH, Thiele EA.

Epilepsy Res. 2011 Sep;96(1-2):172-5. doi: 10.1016/j.eplepsyres.2011.05.012. Epub 2011 Jun 22.

PMID:
21700429
15.

Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA.

Neurology. 2011 Mar 15;76(11):981-7. doi: 10.1212/WNL.0b013e3182104347.

16.

Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review.

van Eeghen AM, Numis AI, Staley BA, Therrien SE, Thibert RL, Thiele EA.

Epilepsy Behav. 2011 Jan;20(1):68-74. doi: 10.1016/j.yebeh.2010.10.023. Epub 2010 Dec 3.

17.

TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.

Muzykewicz DA, Sharma A, Muse V, Numis AL, Rajagopal J, Thiele EA.

J Med Genet. 2009 Jul;46(7):465-8. doi: 10.1136/jmg.2008.065342. Epub 2009 May 5.

PMID:
19419980
18.

Role of mutational analysis in diagnosis of tuberous sclerosis complex.

Vail EA, Rakowski SK, Numis AL, Thiele EA.

Clin Genet. 2009 Mar;75(3):282-5. doi: 10.1111/j.1399-0004.2008.01129.x.

PMID:
19250385
19.
20.

Supplemental Content

Support Center